Jędrysik, M.; Wyszomirski, K.; Różańska-Walędziak, A.; Grosicka-Maciąg, E.; Walędziak, M.; Chełstowska, B.
The Role of GLP-1, GIP, MCP-1 and IGFBP-7 Biomarkers in the Development of Metabolic Disorders: A Review and Predictive Analysis in the Context of Diabetes and Obesity. Biomedicines 2024, 12, 159.
https://doi.org/10.3390/biomedicines12010159
AMA Style
Jędrysik M, Wyszomirski K, Różańska-Walędziak A, Grosicka-Maciąg E, Walędziak M, Chełstowska B.
The Role of GLP-1, GIP, MCP-1 and IGFBP-7 Biomarkers in the Development of Metabolic Disorders: A Review and Predictive Analysis in the Context of Diabetes and Obesity. Biomedicines. 2024; 12(1):159.
https://doi.org/10.3390/biomedicines12010159
Chicago/Turabian Style
Jędrysik, Malwina, Krzysztof Wyszomirski, Anna Różańska-Walędziak, Emilia Grosicka-Maciąg, Maciej Walędziak, and Beata Chełstowska.
2024. "The Role of GLP-1, GIP, MCP-1 and IGFBP-7 Biomarkers in the Development of Metabolic Disorders: A Review and Predictive Analysis in the Context of Diabetes and Obesity" Biomedicines 12, no. 1: 159.
https://doi.org/10.3390/biomedicines12010159
APA Style
Jędrysik, M., Wyszomirski, K., Różańska-Walędziak, A., Grosicka-Maciąg, E., Walędziak, M., & Chełstowska, B.
(2024). The Role of GLP-1, GIP, MCP-1 and IGFBP-7 Biomarkers in the Development of Metabolic Disorders: A Review and Predictive Analysis in the Context of Diabetes and Obesity. Biomedicines, 12(1), 159.
https://doi.org/10.3390/biomedicines12010159
